Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer
Journal of Translational Medicine May 09, 2018
Gu Z, et al. - Researchers evaluated the postprandial fluctuation pattern of cancer-derived CA125 and the underlying mechanism to explore an effective approach to improve the performance of CA125 in early diagnosis of ovarian cancer. Findings revealed a unique and distinctive postprandial pattern of cancer-derived serum CA125. This pattern might distinguish it from the common CA125 elevation in a benign disease condition. The dynamic measurement/assessment strategy seemed to have a potential for providing a discriminatory power superior to that of a static test.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries